Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar franktejon (< 20) Submitted: 11/3/2010 11:15:40 PM : Outperform Start Price: $12.77 AMLN Score: +92.67

top gainer

Featured Broker Partners


Advertisement